Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Acta Neurochirurgica|April 8, 2015
Incidence of local in-brain progression after supramarginal resection of cerebral metastasesMarcel A Kamp, Marion Rapp, Philipp J Slotty, et al.
Research in Developmental Disabilities|December 3, 2014
Predictors of participation of adolescents with cerebral palsy: A European multi-centre longitudinal studyVan Mô Dang, Allan Colver, Heather O Dickinson, et al.
BMC Research Notes|June 19, 2012
Predictors of drop-out in a multi-centre longitudinal study of participation and quality of life of children with cerebral palsyHeather O Dickinson, Marion Rapp, Catherine Arnaud, et al.
Neurosurgical Review|December 21, 2017
Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastasesMarcel A Kamp, Igor Fischer, Maxine Dibué-Adjei, et al.
British Journal of Neurosurgery|August 14, 2019
Diagnostic impact of additional O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET following immunotherapy with dendritic cell vaccination in glioblastoma patientsAnn Kristin Schmitz, Rüdiger V Sorg, Gabriele Stoffels, et al.
Scientific Reports|May 17, 2019
Risk factors for in-brain local progression in elderly patients after resection of cerebral metastasesChristopher Munoz-Bendix, Marion Rapp, Hendrik-Jan Mijderwijk, et al.
Journal of Neuro-Oncology|December 12, 2018
Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival?Marcel A Kamp, Christopher Munoz-Bendix, Hendrik-Jan Mijderwijk, et al.
World Neurosurgery|July 28, 2019
Is the Intensity of 5-Aminolevulinic Acid-Derived Fluorescence Related to the Light Source?Marcel A Kamp, Johannes Knipps, Lisa Margarete Neumann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2013
Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade gliomaNorbert Galldiks, Gabriele Stoffels, Maximilian I Ruge, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2018
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experienceGarry Ceccon, Lazaros Lazaridis, Gabriele Stoffels, et al.
Pageof 13